Dr. Christian Meyer and Dr. Gisela Grabow discuss potential changes to the EU pharmaceutical regulation and their possible impact on data and market protection timelines for medicinal products.
EU pharmaceutical reforms propose changes to regulatory protection periods, Managing IP 2024
To the publication
